by David Kent | Oct 30, 2014
> One of the consistent themes of the Till and McCulloch Meetings (#TMM2014) is its commitment to having students and postdocs on stage presenting their work. These sessions have been regularly cited by my colleagues as the most interesting and engaging sessions...
by David Kent | Oct 29, 2014
> One of my favourite things about the Till and McCulloch Meetings (#TMM2014) is the careful thought that goes into session organization. The balance of basic science, ethics, engineering, and industrial and clinical applications has always been a nice feature of...
by David Kent | Oct 28, 2014
> Last month, Signals re-posted a blog entry of mine from The Black Hole where I lamented the lack of teamwork in the life sciences. There are, however, always exceptions and I want to highlight one such exception that took the field of blood stem cell expansion by...
by Ben Paylor | Oct 24, 2014
> Just over one year ago, we launched the pilot phase of an animation project titled StemCellShorts here on Signals blog. Funded by a Stem Cell Network Public Outreach Award, the project was very much an experiment for us to see what would happen when you tasked a...
by Lisa Willemse | Oct 20, 2014
> Next week, close to 500 researchers, clinicians, trainees, industry and government representatives will gather in Ottawa for some of the best the stem cell and regenerative medicine research community has to offer. The third Till & McCulloch Meetings is...
by Stacey Johnson | Oct 17, 2014
. I don’t disagree with that quote by educator and humanitarian Helen Keller, a woman who overcame her inability to see, hear and speak, and graduated from college in 1904. However, I’m extremely squeamish when it comes to eyes. Perhaps it started in grade 8 science...
by Mark Curtis | Oct 14, 2014
. Welcome to your Update from the Clinic for the month of September. There’s a mixture of news from the cancer stem cell companies and immunotherapy companies this past month. Amongst other things, the FDA removed the previously imposed partial hold on one of...
by Lisa Willemse | Oct 10, 2014
> We assume there is no real argument to be made here. It’s more than just popularity or who has been in the news most often over the past year. The annual call for nominations and the selection of Stem Cell Person of the Year by readers of Paul...
by Mark Curtis | Oct 9, 2014
Welcome to your deal review for the month of September. There was some healthy news flow around cell-based immunotherapy companies this past month, heating up a space that is already ablaze with activity. Undoubtedly the company that took the spotlight was...
by Holly Wobma | Oct 6, 2014
> “Wow, my mouth just got diabetes.” Such are my immediate thoughts after taking a bite out of a red velvet cupcake. Though I must qualify: by cupcake, I mean a skyscraper of frosting carefully balanced on a minimal crumbly foundation. Making such a hyperbolic...
Comments